Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 4
- Adult 4
- Anti-HIV Agents 3
- Anti-Retroviral Agents 1
- Antiretroviral Therapy, Highly Active 2
- Article 1
- Botswana 3
- Circumcision, Male 2
- Community Health Services 1
- Continuity of Patient Care 1
- Family Characteristics 1
- Female 4
- Goals 1
- HIV-1 2
- HIV Infections 4
- Humans 4
- Incidence 2
- Longitudinal Studies 1
- Male 4
- Mass Drug Administration 1
- Mass Screening 2
- Middle Aged 4
- Prevalence 2
- Proportional Hazards Models 1
- RNA, Viral 2
- Rural Population 2
- Socioeconomic Factors 1
- Surveys and Questionnaires 3
- United Nations 1
- Viral Load 4
- Young Adult 4
Personal Author
Corporate Author
Place as Subject
- Botswana 1
Resource Type General
Keywords
Select all docs (Max 200)
1 -
5 of 5 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (4)
- Adult (4)
- Anti-HIV Agents (3)
- Anti-Retroviral Agents (1)
- Antiretroviral Therapy, Highly Active (2)
- Article (1)
- Botswana (3)
- Circumcision, Male (2)
- Community Health Services (1)
- Continuity of Patient Care (1)
- Family Characteristics (1)
- Female (4)
- Goals (1)
- HIV-1 (2)
- HIV Infections (4)
- Humans (4)
- Incidence (2)
- Longitudinal Studies (1)
- Male (4)
- Mass Drug Administration (1)
- Mass Screening (2)
- Middle Aged (4)
- Prevalence (2)
- Proportional Hazards Models (1)
- RNA, Viral (2)
- Rural Population (2)
- Socioeconomic Factors (1)
- Surveys and Questionnaires (3)
- United Nations (1)
- Viral Load (4)
- Young Adult (4)
- Botswana (1)
- cluster randomized trials (1)
- design effect (1)
- HIV-1C epidemic (1)
- HIV Infections (1)
- HIV prevention (1)
- HIV suppression (1)
- Humans (1)
- Incidence (1)
- network models (1)
- Randomized Controlled Trials as Topic (1)
- receiving ART (1)
- Research Design (1)
- Sample Size (1)
- virologically suppressed (1)
- young adults (1)
- :Wang, Rui ;Goyal, Ravi6 2014 | Clin Trials. 11(3):309-318:BackgroundCluster randomized trials have been utilized to evaluate the effectiveness of human immunodeficiency virus (HIV) prevention strategies on re...
- :Wirth, Kathleen E. ;Gaolathe, Tendani6 2020 | Lancet HIV. 7(6):e422-e433:BackgroundWe sought to determine whether a community-based intervention to identify and rapidly treat persons living with HIV (PLWH) and support male ...
- :Makhema, J. ;Wirth, K.E.July 18 2019 | N Engl J Med. 381(3):230-242:BACKGROUNDThe feasibility of reducing the population-level incidence of human immunodeficiency virus (HIV) infection by increasing community coverage ...
- :Novitsky, Vlad ;Gaolathe, Tendani8 15 2018 | J Acquir Immune Defic Syndr. 78(5):557-565:Background:HIV-1 RNA load is the best biological predictor of HIV transmission and treatment response. The rate of virologic suppression among key sub...
- :Gaolathe, Tendani ;Wirth, Kathleen E.5 2016 | Lancet HIV. 3(5):e221-e230:BackgroundGlobal HIV programs continue to experience challenges achieving the high rates of HIV testing and treatment needed to optimize health and re...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.